Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,741 | 564 | 180 | 808 | 916 |
| Marketable Securities | N/A | N/A | 552 | N/A | N/A |
| Receivables | 254 | N/A | N/A | N/A | N/A |
| TOTAL | $4,995 | $566 | $734 | $832 | $956 |
| Non-Current Assets | |||||
| PPE Net | 2,035 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 195 | 0 | 0 | 43 | 67 |
| TOTAL | $2,230 | $N/A | $N/A | $43 | $67 |
| Total Assets | $7,225 | $566 | $734 | $875 | $1,023 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 845 | 4 | 79 | 79 | 77 |
| Accrued Expenses | N/A | 66 | N/A | N/A | N/A |
| TOTAL | $845 | $71 | $79 | $79 | $77 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 285 | 0 | 0 | 0 | 0 |
| TOTAL | $285 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,130 | $71 | $79 | $79 | $77 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58 | 29 | 29 | 29 | 29 |
| Common Shares | 19 | 0 | 0 | 0 | 0 |
| Retained earnings | -11,122 | -3,738 | -3,578 | -3,437 | -3,287 |
| Other shareholders' equity | 1,028 | 0 | 0 | 0 | 0 |
| TOTAL | $6,095 | $495 | $655 | $796 | $946 |
| Total Liabilities And Equity | $7,225 | $566 | $734 | $875 | $1,023 |